Acorda Therapeutics

• Founded

  Mar 17, 1995

Sources: search.gleif.org

• A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets

  Phase 1, Completed, 24 people, Jun 24, 2016

• Randomized Safety Study of CVT-301 Compared to an Observational Control Group

  Phase 3, Completed, 408 people, Feb 2, 2015

• NCT02242487

  Phase 3, Completed, 325 people, Sep 17, 2014

• NCT02240030

  Phase 3, Completed, 351 people, Sep 15, 2014

• NCT01975324

  Collaborator, Phase 4, Completed, 20 people, Nov 4, 2013

• NCT01944683

  Phase 1, Completed, 22 people, Sep 18, 2013

• NCT01617135

  Phase 2, Completed, 25 people, Jun 12, 2012

• NCT01356940

  Collaborator, Phase 4, Completed, 43 people, May 20, 2011

Sources: clinicaltrials.gov